Blood sugar control: Insulin degludec better than insulin glargine, reveal results from CONCLUDE trial Medha Baranwal Baranwal19 Sept 2019 8:20 PM ISTLow blood sugar or hypoglycemia is the most common side effect of insulin glargine -- used for the management of diabetes. Now, a recent study seemed...
Diabetes drug: Thiazolidines increase fracture risk in elderly diabetics Medha Baranwal Baranwal20 Sept 2019 7:28 PM ISTJapan: The use of diabetes drugs belonging to thiazolidines (TZD) group increase the risk of fracture in elderly patients with type 2 diabetes...
Gluten intake during early childhood linked to increased risk of Type 1 diabetes Dr. Kamal Kant Kohli Kohli20 Sept 2019 7:25 PM ISTChild's intake of gluten during early childhood is associated with increased risk of developing type 1 diabetes, reveals new research presented by Dr...
Dapagliflozin is new treatment for heart failure, finds NEJM study Dr. Kamal Kant Kohli Kohli20 Sept 2019 8:28 PM ISTHeart failure occurs when the heart is no longer able to efficiently pump blood in the body as it should. Diuretics and Ace inhibitors have been the...
Long term use of ACE inhibitors not only lowers BP, but reduces diabetes risk also Hina Zahid21 Sept 2019 8:55 AM ISTAngiotensin-converting enzyme (ACE) inhibitors are high blood pressure drugs that dilate blood vessels to increase blood flow and lower high blood...
FDA approves first ever oral Semaglutide for blood sugar control in type 2 diabetes Dr. Kamal Kant Kohli Kohli20 Sept 2019 8:20 PM ISTFood and Drug Administration has approved first GLP-1 oral drug Semaglutide for blood sugar control in type 2 diabetes.The U.S. Food and Drug...
Vildagliptin, Metformin combo shows long term blood sugar control in newly diagnosed diabetics Deepanjana Sarkar23 Sept 2019 8:30 PM ISTBarcelona, Spain: Results from a recent Phase IV clinical study--VERIFY-- has shown better blood sugar control in patients who are on Early...
New research targets metformin as breast cancer prescription: International Journal of Cancer Hina Zahid24 Sept 2019 7:15 PM ISTMetformin is a first-line treatment for type 2 diabetes and prediabetes. It is a cost-effective and popular and safe drug. Lately, Metformin has found...
Study finds noninferior cardiovascular safety of linagliptin versus glimepiride in early diabetes Deepanjana Sarkar25 Sept 2019 9:00 AM ISTThe dipeptidyl peptidase-4 inhibitor-linagliptin has demonstrated noninferiority in placebo-controlled cardiovascular safety trials however, its role...
Elevated hs-CRP ups risk of diabetic nephropathy in diabetes patients: Diabetes Care Medha Baranwal Baranwal24 Sept 2019 8:28 PM ISTThe role of low-grade systemic inflammation as evidenced by elevated high sensitivity C-reactive protein (hsCRP) levels in the pathogenesis of...
Diabetics with raised blood sugar have higher risk of frailty later in life Medha Baranwal Baranwal26 Sept 2019 8:55 AM ISTDelhi: People with overt diabetes or raised HbA1c or fasting blood sugar levels have a higher risk of frailty throughout later life. Non-frail...
Modify risk rather than merely relying on blood sugar lowering drugs in diabetes: DECLARE-TIMI Medha Baranwal Baranwal27 Sept 2019 7:28 PM ISTModify risk rather than merely relying on blood sugar lowering drugs in diabetes, finds DECLARE-TIMI Phase IIIB trial.Researchers, based on their...
